Mahadev Rx Corporation
Community/Retail Pharmacy
777 Washington Rd, Parlin
New Jersey, 08859-1074
732-238-4022 732-238-5921
Mahadev Rx Corporation is a Community/Retail Pharmacy in Parlin, New Jersey. It is located at 777 Washington Rd, Parlin and it's customer support contact number is 732-238-4022. The authorized person of Mahadev Rx Corporation is Ravi Shingala who is Officer of the pharmacy and his contact number is 732-238-4022. Active license number of Mahadev Rx Corporation is 28RS00389900 for Community/Retail Pharmacy in New Jersey. Mahadev Rx Corporation accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Mahadev Rx Corporation is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Mahadev Rx Corporation type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Mahadev Rx Corporation |
| Type: | Community/Retail Pharmacy |
| Location: | 777 Washington Rd, Parlin,
New Jersey, 08859-1074 |
| Phone: | 732-238-4022 |
| Fax: | 732-238-5921 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Ravi Shingala |
| Position: | Officer |
| Contact Number: | 732-238-4022 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1154456291 |
| NPI Enumeration Date: | 22 Feb, 2007 |
| NPI Last Update On: | 13 Aug, 2025 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mahadev Rx Corporation are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | 28RS00389900 | New Jersey | Primary | |
| Pharmacy | 28RS00389900 | New Jersey | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 4380509 | Medicaid | New Jersey | |
| 3128344 | Other | | Other Id Number-commercial Number |
Medicare Enrollment:
Mahadev Rx Corporation is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 8022133594 | O20100923000164 | Quick Chek Corporation | PART B SUPPLIER - MASS IMMUNIZATION (ROSTER BILLER ONLY) |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 777 Washington Rd,
Parlin, New Jersey |
| Zip: | 08859-1074 |
| Phone Number: | 732-238-4022 |
| Fax Number: | 732-238-5921 |
Patients can reach Mahadev Rx Corporation at
777 Washington Rd, Parlin, New Jersey or can
call on customer care at 732-238-4022.
Comments/ Reviews:
Read all the reviews posted for Mahadev Rx Corporation below. You may also share your own experience with Mahadev Rx Corporation. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.